SA, UK, USA
Currently reside in Rhode Island

Nephrology fellowship in Chicago, then a faculty position at the University of Chicago.

Active in RI responds - Rhode Island response force to COVID-19.

Brief Bio
M. Roy First, M.D. is an Independent Consultant since January 2020. Previously he was the Vice President, Medical Affairs, Transplant Genomics, Inc./Viracor-Eurofins and Chief Medical Officer at Transplant Genomics, Inc. Prior to that he was Vice President and Global Therapeutic Area Leader, Transplantation at Astellas Pharma Global Development, Inc. He graduated from medical school at the University of Witwatersrand in 1966, and was elected as a Fellow of the College of Physicians (FCP {SA}) in 1970. After completing his training in Johannesburg, South Africa, he moved to Chicago in 1972 to take the position of Renal Research Fellow at the Michael Reese Hospital. In 1974, he was appointed Assistant Professor of Medicine in the Division of Nephrology at the University of Cincinnati, later becoming full Professor and Director of the Section of Transplantation, a position that he held until 2002, when he moved to Fujisawa (later Astellas). He is board certified in Internal Medicine and in Nephrology (both in 1976). During his distinguished academic career, Dr. First has published 408 articles on transplantation, as well as 39 book chapters and two books. He is a past President of the American Society of Transplantation (AST) and has served on many United Network for Organ Sharing (UNOS) committees, including chairing the Organ Donation Committee, on the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA), as a reviewer for the National Institutes of Health (NIH), on the NIH Data Safety and Monitoring Board for Clinical Trials in Transplantation, and as a Councilor of the Transplantation Society. Dr. First has been on the editorial board of a number of journals including Transplantation, Transplantation Proceedings, Clinical Transplantation, the American Journal of Transplantation, and the Journal of the American Society of Nephrology. In 2013 he received the AST Lifetime Achievement Award. Elected as a Fellow of the American Society of Transplantation (FAST) in April 2016.